[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Enzyme Replacement Therapy (ERT) Drugs Market Growth 2024-2030

July 2024 | 124 pages | ID: G55353328CBFEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Enzyme replacement therapy (ERT) is a medical treatment whereby replacement enzymes are given to patients who suffer from chronic conditions resulting from enzyme deficiencies or malfunction. The most common method of ERT is through IV infusions, in which the replacement enzyme is administered directly into the bloodstream through a controlled drip of fluids. Replacement enzymes for ERT are derived from human, animal, and plant cells that are then genetically modified and processed before being given to the patient. By receiving these enzyme replacements, the body is able to successfully perform the functions inhibited by the deficiency. The effectiveness of ERT varies from person to person and what is being treated, but in some cases it is the only available treatment option.

The global Enzyme Replacement Therapy (ERT) Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Enzyme Replacement Therapy (ERT) Drugs Industry Forecast” looks at past sales and reviews total world Enzyme Replacement Therapy (ERT) Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Enzyme Replacement Therapy (ERT) Drugs sales for 2024 through 2030. With Enzyme Replacement Therapy (ERT) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzyme Replacement Therapy (ERT) Drugs industry.

This Insight Report provides a comprehensive analysis of the global Enzyme Replacement Therapy (ERT) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzyme Replacement Therapy (ERT) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enzyme Replacement Therapy (ERT) Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzyme Replacement Therapy (ERT) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzyme Replacement Therapy (ERT) Drugs.

United States market for Enzyme Replacement Therapy (ERT) Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Enzyme Replacement Therapy (ERT) Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Enzyme Replacement Therapy (ERT) Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Enzyme Replacement Therapy (ERT) Drugs players cover Sanofi, Takeda, BioMarin, AbbVie, Alexion, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Enzyme Replacement Therapy (ERT) Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Oral Treatment
  • Injection Treatment
Segmentation by Application:
  • Fabry Disease
  • Gaucher Disease
  • Pompe Disease
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Sanofi
  • Takeda
  • BioMarin
  • AbbVie
  • Alexion
  • Allergan
  • Horizon Pharma
  • Johnson & Johnson
  • Actelion
  • Recordati Rare Diseases
  • Pfizer
  • Digestive Care
  • Leadiant Biosciences
Key Questions Addressed in this Report

What is the 10-year outlook for the global Enzyme Replacement Therapy (ERT) Drugs market?

What factors are driving Enzyme Replacement Therapy (ERT) Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Enzyme Replacement Therapy (ERT) Drugs market opportunities vary by end market size?

How does Enzyme Replacement Therapy (ERT) Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Enzyme Replacement Therapy (ERT) Drugs Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Enzyme Replacement Therapy (ERT) Drugs by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Enzyme Replacement Therapy (ERT) Drugs by Country/Region, 2019, 2023 & 2030
2.2 Enzyme Replacement Therapy (ERT) Drugs Segment by Type
  2.2.1 Oral Treatment
  2.2.2 Injection Treatment
2.3 Enzyme Replacement Therapy (ERT) Drugs Sales by Type
  2.3.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
  2.3.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Enzyme Replacement Therapy (ERT) Drugs Sale Price by Type (2019-2024)
2.4 Enzyme Replacement Therapy (ERT) Drugs Segment by Application
  2.4.1 Fabry Disease
  2.4.2 Gaucher Disease
  2.4.3 Pompe Disease
  2.4.4 Other
2.5 Enzyme Replacement Therapy (ERT) Drugs Sales by Application
  2.5.1 Global Enzyme Replacement Therapy (ERT) Drugs Sale Market Share by Application (2019-2024)
  2.5.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Enzyme Replacement Therapy (ERT) Drugs Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Enzyme Replacement Therapy (ERT) Drugs Breakdown Data by Company
  3.1.1 Global Enzyme Replacement Therapy (ERT) Drugs Annual Sales by Company (2019-2024)
  3.1.2 Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Company (2019-2024)
3.2 Global Enzyme Replacement Therapy (ERT) Drugs Annual Revenue by Company (2019-2024)
  3.2.1 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Company (2019-2024)
  3.2.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Enzyme Replacement Therapy (ERT) Drugs Sale Price by Company
3.4 Key Manufacturers Enzyme Replacement Therapy (ERT) Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Enzyme Replacement Therapy (ERT) Drugs Product Location Distribution
  3.4.2 Players Enzyme Replacement Therapy (ERT) Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ENZYME REPLACEMENT THERAPY (ERT) DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Enzyme Replacement Therapy (ERT) Drugs Market Size by Geographic Region (2019-2024)
  4.1.1 Global Enzyme Replacement Therapy (ERT) Drugs Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Enzyme Replacement Therapy (ERT) Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Enzyme Replacement Therapy (ERT) Drugs Market Size by Country/Region (2019-2024)
  4.2.1 Global Enzyme Replacement Therapy (ERT) Drugs Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Enzyme Replacement Therapy (ERT) Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Enzyme Replacement Therapy (ERT) Drugs Sales Growth
4.4 APAC Enzyme Replacement Therapy (ERT) Drugs Sales Growth
4.5 Europe Enzyme Replacement Therapy (ERT) Drugs Sales Growth
4.6 Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales Growth

5 AMERICAS

5.1 Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Country
  5.1.1 Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024)
  5.1.2 Americas Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024)
5.2 Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024)
5.3 Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Region
  6.1.1 APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2019-2024)
  6.1.2 APAC Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2019-2024)
6.2 APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024)
6.3 APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Enzyme Replacement Therapy (ERT) Drugs by Country
  7.1.1 Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024)
  7.1.2 Europe Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024)
7.2 Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024)
7.3 Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs by Country
  8.1.1 Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzyme Replacement Therapy (ERT) Drugs
10.3 Manufacturing Process Analysis of Enzyme Replacement Therapy (ERT) Drugs
10.4 Industry Chain Structure of Enzyme Replacement Therapy (ERT) Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Enzyme Replacement Therapy (ERT) Drugs Distributors
11.3 Enzyme Replacement Therapy (ERT) Drugs Customer

12 WORLD FORECAST REVIEW FOR ENZYME REPLACEMENT THERAPY (ERT) DRUGS BY GEOGRAPHIC REGION

12.1 Global Enzyme Replacement Therapy (ERT) Drugs Market Size Forecast by Region
  12.1.1 Global Enzyme Replacement Therapy (ERT) Drugs Forecast by Region (2025-2030)
  12.1.2 Global Enzyme Replacement Therapy (ERT) Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Enzyme Replacement Therapy (ERT) Drugs Forecast by Type (2025-2030)
12.7 Global Enzyme Replacement Therapy (ERT) Drugs Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.1.3 Sanofi Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 Takeda
  13.2.1 Takeda Company Information
  13.2.2 Takeda Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.2.3 Takeda Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Takeda Main Business Overview
  13.2.5 Takeda Latest Developments
13.3 BioMarin
  13.3.1 BioMarin Company Information
  13.3.2 BioMarin Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.3.3 BioMarin Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 BioMarin Main Business Overview
  13.3.5 BioMarin Latest Developments
13.4 AbbVie
  13.4.1 AbbVie Company Information
  13.4.2 AbbVie Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.4.3 AbbVie Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 AbbVie Main Business Overview
  13.4.5 AbbVie Latest Developments
13.5 Alexion
  13.5.1 Alexion Company Information
  13.5.2 Alexion Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.5.3 Alexion Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Alexion Main Business Overview
  13.5.5 Alexion Latest Developments
13.6 Allergan
  13.6.1 Allergan Company Information
  13.6.2 Allergan Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.6.3 Allergan Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Allergan Main Business Overview
  13.6.5 Allergan Latest Developments
13.7 Horizon Pharma
  13.7.1 Horizon Pharma Company Information
  13.7.2 Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.7.3 Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Horizon Pharma Main Business Overview
  13.7.5 Horizon Pharma Latest Developments
13.8 Johnson & Johnson
  13.8.1 Johnson & Johnson Company Information
  13.8.2 Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.8.3 Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Johnson & Johnson Main Business Overview
  13.8.5 Johnson & Johnson Latest Developments
13.9 Actelion
  13.9.1 Actelion Company Information
  13.9.2 Actelion Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.9.3 Actelion Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Actelion Main Business Overview
  13.9.5 Actelion Latest Developments
13.10 Recordati Rare Diseases
  13.10.1 Recordati Rare Diseases Company Information
  13.10.2 Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.10.3 Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Recordati Rare Diseases Main Business Overview
  13.10.5 Recordati Rare Diseases Latest Developments
13.11 Pfizer
  13.11.1 Pfizer Company Information
  13.11.2 Pfizer Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.11.3 Pfizer Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Pfizer Main Business Overview
  13.11.5 Pfizer Latest Developments
13.12 Digestive Care
  13.12.1 Digestive Care Company Information
  13.12.2 Digestive Care Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.12.3 Digestive Care Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Digestive Care Main Business Overview
  13.12.5 Digestive Care Latest Developments
13.13 Leadiant Biosciences
  13.13.1 Leadiant Biosciences Company Information
  13.13.2 Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
  13.13.3 Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 Leadiant Biosciences Main Business Overview
  13.13.5 Leadiant Biosciences Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Enzyme Replacement Therapy (ERT) Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Enzyme Replacement Therapy (ERT) Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oral Treatment
Table 4. Major Players of Injection Treatment
Table 5. Global Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024) & (K Units)
Table 6. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
Table 7. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Type (2019-2024) & ($ million)
Table 8. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Type (2019-2024)
Table 9. Global Enzyme Replacement Therapy (ERT) Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Enzyme Replacement Therapy (ERT) Drugs Sale by Application (2019-2024) & (K Units)
Table 11. Global Enzyme Replacement Therapy (ERT) Drugs Sale Market Share by Application (2019-2024)
Table 12. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Application (2019-2024) & ($ million)
Table 13. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Application (2019-2024)
Table 14. Global Enzyme Replacement Therapy (ERT) Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Enzyme Replacement Therapy (ERT) Drugs Sales by Company (2019-2024) & (K Units)
Table 16. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Company (2019-2024)
Table 17. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Company (2019-2024)
Table 19. Global Enzyme Replacement Therapy (ERT) Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Enzyme Replacement Therapy (ERT) Drugs Producing Area Distribution and Sales Area
Table 21. Players Enzyme Replacement Therapy (ERT) Drugs Products Offered
Table 22. Enzyme Replacement Therapy (ERT) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Enzyme Replacement Therapy (ERT) Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share Geographic Region (2019-2024)
Table 27. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Enzyme Replacement Therapy (ERT) Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country/Region (2019-2024)
Table 31. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
Table 34. Americas Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country (2019-2024)
Table 35. Americas Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024) & (K Units)
Table 37. Americas Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024) & (K Units)
Table 38. APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2019-2024) & (K Units)
Table 39. APAC Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Region (2019-2024)
Table 40. APAC Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024) & (K Units)
Table 42. APAC Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024) & (K Units)
Table 43. Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
Table 44. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024) & (K Units)
Table 46. Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Enzyme Replacement Therapy (ERT) Drugs
Table 52. Key Market Challenges & Risks of Enzyme Replacement Therapy (ERT) Drugs
Table 53. Key Industry Trends of Enzyme Replacement Therapy (ERT) Drugs
Table 54. Enzyme Replacement Therapy (ERT) Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Enzyme Replacement Therapy (ERT) Drugs Distributors List
Table 57. Enzyme Replacement Therapy (ERT) Drugs Customer List
Table 58. Global Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Enzyme Replacement Therapy (ERT) Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Enzyme Replacement Therapy (ERT) Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Enzyme Replacement Therapy (ERT) Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Sanofi Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 74. Sanofi Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. Takeda Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Takeda Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 79. Takeda Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Takeda Main Business
Table 81. Takeda Latest Developments
Table 82. BioMarin Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. BioMarin Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 84. BioMarin Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. BioMarin Main Business
Table 86. BioMarin Latest Developments
Table 87. AbbVie Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 89. AbbVie Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Alexion Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Alexion Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 94. Alexion Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Alexion Main Business
Table 96. Alexion Latest Developments
Table 97. Allergan Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Allergan Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 99. Allergan Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Allergan Main Business
Table 101. Allergan Latest Developments
Table 102. Horizon Pharma Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 104. Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Horizon Pharma Main Business
Table 106. Horizon Pharma Latest Developments
Table 107. Johnson & Johnson Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 109. Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Actelion Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Actelion Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 114. Actelion Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Actelion Main Business
Table 116. Actelion Latest Developments
Table 117. Recordati Rare Diseases Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 119. Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Recordati Rare Diseases Main Business
Table 121. Recordati Rare Diseases Latest Developments
Table 122. Pfizer Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Pfizer Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 124. Pfizer Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Pfizer Main Business
Table 126. Pfizer Latest Developments
Table 127. Digestive Care Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Digestive Care Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 129. Digestive Care Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Digestive Care Main Business
Table 131. Digestive Care Latest Developments
Table 132. Leadiant Biosciences Basic Information, Enzyme Replacement Therapy (ERT) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Product Portfolios and Specifications
Table 134. Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Leadiant Biosciences Main Business
Table 136. Leadiant Biosciences Latest Developments



LIST OF FIGURES

Figure 1. Picture of Enzyme Replacement Therapy (ERT) Drugs
Figure 2. Enzyme Replacement Therapy (ERT) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzyme Replacement Therapy (ERT) Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Enzyme Replacement Therapy (ERT) Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country/Region (2023)
Figure 10. Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Oral Treatment
Figure 12. Product Picture of Injection Treatment
Figure 13. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type in 2023
Figure 14. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Type (2019-2024)
Figure 15. Enzyme Replacement Therapy (ERT) Drugs Consumed in Fabry Disease
Figure 16. Global Enzyme Replacement Therapy (ERT) Drugs Market: Fabry Disease (2019-2024) & (K Units)
Figure 17. Enzyme Replacement Therapy (ERT) Drugs Consumed in Gaucher Disease
Figure 18. Global Enzyme Replacement Therapy (ERT) Drugs Market: Gaucher Disease (2019-2024) & (K Units)
Figure 19. Enzyme Replacement Therapy (ERT) Drugs Consumed in Pompe Disease
Figure 20. Global Enzyme Replacement Therapy (ERT) Drugs Market: Pompe Disease (2019-2024) & (K Units)
Figure 21. Enzyme Replacement Therapy (ERT) Drugs Consumed in Other
Figure 22. Global Enzyme Replacement Therapy (ERT) Drugs Market: Other (2019-2024) & (K Units)
Figure 23. Global Enzyme Replacement Therapy (ERT) Drugs Sale Market Share by Application (2023)
Figure 24. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Application in 2023
Figure 25. Enzyme Replacement Therapy (ERT) Drugs Sales by Company in 2023 (K Units)
Figure 26. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Company in 2023
Figure 27. Enzyme Replacement Therapy (ERT) Drugs Revenue by Company in 2023 ($ millions)
Figure 28. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Company in 2023
Figure 29. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Enzyme Replacement Therapy (ERT) Drugs Sales 2019-2024 (K Units)
Figure 32. Americas Enzyme Replacement Therapy (ERT) Drugs Revenue 2019-2024 ($ millions)
Figure 33. APAC Enzyme Replacement Therapy (ERT) Drugs Sales 2019-2024 (K Units)
Figure 34. APAC Enzyme Replacement Therapy (ERT) Drugs Revenue 2019-2024 ($ millions)
Figure 35. Europe Enzyme Replacement Therapy (ERT) Drugs Sales 2019-2024 (K Units)
Figure 36. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Revenue 2019-2024 ($ millions)
Figure 39. Americas Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country in 2023
Figure 40. Americas Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2024)
Figure 41. Americas Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
Figure 42. Americas Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2019-2024)
Figure 43. United States Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Region in 2023
Figure 48. APAC Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Region (2019-2024)
Figure 49. APAC Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
Figure 50. APAC Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2019-2024)
Figure 51. China Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. India Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country in 2023
Figure 59. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2024)
Figure 60. Europe Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
Figure 61. Europe Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2019-2024)
Figure 62. Germany Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. France Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2019-2024)
Figure 70. Egypt Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Enzyme Replacement Therapy (ERT) Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Enzyme Replacement Therapy (ERT) Drugs in 2023
Figure 76. Manufacturing Process Analysis of Enzyme Replacement Therapy (ERT) Drugs
Figure 77. Industry Chain Structure of Enzyme Replacement Therapy (ERT) Drugs
Figure 78. Channels of Distribution
Figure 79. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Forecast by Region (2025-2030)
Figure 80. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share Forecast by Application (2025-2030)


More Publications